Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial (Q33945171)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial
scientific article

    Statements

    Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial (English)
    Sébastien Gallien
    Joséphine Braun
    Isabelle Charreau
    Jacques Reynes
    François Jeanblanc
    Renaud Verdon
    Pierre de Truchis
    Isabelle Madelaine-Chambrin
    Jean-Pierre Aboulker
    EASIER ANRS 138 Study Group
    2099-2106

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit